3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
2
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Psoriasis
1
Prostatic Neoplasms
1
Interventions
Etanercept
3
Methotrexate
2
Adalimumab
2
secukinumab
1
purine
1
fumaric acid
1
deucravacitinib
1
apremilast
1
Vitamin D
1
Vaccines
1
Sulfasalazine
1
Standard of Care
1
Saline Solution
1
Practice Guidelines as Topic
1
Nivolumab
1
Methods
1
Mesalamine
1
Mercaptopurine
1
Interviews as Topic
1
Infliximab
1
Herpes Zoster Vaccine
1
Folic Acid
1
Fish Oils
1
Fatty Acids, Omega-3
1
Exercise
1
Eicosapentaenoic Acid
1
Educational Status
1
Eating
1
Early Intervention, Educational
1
Docosahexaenoic Acids
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Psoriasis
×
deucravacitinib
×
Clear all
NCT06281106
2025-04-02
TYPP
Centre Hospitalier Universitaire Vaudois
Phase 2/3
Terminated
2 enrolled